1. Home
  2. ATPC vs IVVD Comparison

ATPC vs IVVD Comparison

Compare ATPC & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATPC
  • IVVD
  • Stock Information
  • Founded
  • ATPC 2016
  • IVVD 2020
  • Country
  • ATPC Malaysia
  • IVVD United States
  • Employees
  • ATPC N/A
  • IVVD N/A
  • Industry
  • ATPC Medical/Nursing Services
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATPC Health Care
  • IVVD Health Care
  • Exchange
  • ATPC Nasdaq
  • IVVD Nasdaq
  • Market Cap
  • ATPC 67.3M
  • IVVD 63.4M
  • IPO Year
  • ATPC N/A
  • IVVD 2021
  • Fundamental
  • Price
  • ATPC $1.29
  • IVVD $1.16
  • Analyst Decision
  • ATPC
  • IVVD Strong Buy
  • Analyst Count
  • ATPC 0
  • IVVD 4
  • Target Price
  • ATPC N/A
  • IVVD $3.64
  • AVG Volume (30 Days)
  • ATPC 43.9K
  • IVVD 13.8M
  • Earning Date
  • ATPC 08-13-2025
  • IVVD 08-14-2025
  • Dividend Yield
  • ATPC N/A
  • IVVD N/A
  • EPS Growth
  • ATPC N/A
  • IVVD N/A
  • EPS
  • ATPC N/A
  • IVVD N/A
  • Revenue
  • ATPC $1,445,601.00
  • IVVD $46,210,000.00
  • Revenue This Year
  • ATPC N/A
  • IVVD $385.94
  • Revenue Next Year
  • ATPC N/A
  • IVVD $62.62
  • P/E Ratio
  • ATPC N/A
  • IVVD N/A
  • Revenue Growth
  • ATPC 4.90
  • IVVD 1941.08
  • 52 Week Low
  • ATPC $0.90
  • IVVD $0.35
  • 52 Week High
  • ATPC $2.95
  • IVVD $2.74
  • Technical
  • Relative Strength Index (RSI)
  • ATPC 44.65
  • IVVD 66.84
  • Support Level
  • ATPC $1.26
  • IVVD $0.96
  • Resistance Level
  • ATPC $1.35
  • IVVD $1.14
  • Average True Range (ATR)
  • ATPC 0.07
  • IVVD 0.14
  • MACD
  • ATPC 0.00
  • IVVD 0.05
  • Stochastic Oscillator
  • ATPC 25.00
  • IVVD 93.12

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: